All In MedTech

FDA Clearance Tracker · P070026-S114

DePuy Ceramax Ceramic Total Hip System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 19, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P070026-S114
Device name
DePuy Ceramax Ceramic Total Hip System
Applicant location
Warsaw, IN
Received
Sep 19, 2024
Decided
Mar 19, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P070026

Device type

Device class
Class III

Every decision under product code MRA

FDA's approval statement

As written in FDA's record.

Approval for revisions to device labeling that was updated to include information on the Post-Approval Study (PAS), Short-Mid-Term F/u of New COC36 Patients, for the DePuy Ceramax Ceramic Total Hip System

Source documents

Other decisions for DePuy Orthopaedics, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.